Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery. 1990

J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD 20892.

Sera from 5,244 blood donations collected between 1979 and 1987 were screened for antibody to HTLV-I with an enzyme immunoassay (EIA) whose result was confirmed with a two-step procedure including Western blot (WB) and radio immunoprecipitation. Of 20 repeatedly reactive samples, two were confirmed positive for HTLV-I infection. These blood units were transfused to patients undergoing cardiac surgery. Both recipients of the confirmed anti-HTLV-I positive units were infected with HTLV-I as evidenced by antibody seroconversion. In contrast, six recipients of EIA positive, WB indeterminate blood and nine recipients WB negative blood were not infected with HTLV-I. These results confirm a low prevalence of HTLV-I infection in US blood donors, the capacity of infected units to transmit the virus to recipients, and the importance of an appropriate confirmatory assay.

UI MeSH Term Description Entries
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006348 Cardiac Surgical Procedures Surgery performed on the heart. Cardiac Surgical Procedure,Heart Surgical Procedure,Heart Surgical Procedures,Procedure, Cardiac Surgical,Procedure, Heart Surgical,Procedures, Cardiac Surgical,Procedures, Heart Surgical,Surgical Procedure, Cardiac,Surgical Procedure, Heart,Surgical Procedures, Cardiac,Surgical Procedures, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015482 HTLV-II Antibodies Antibodies reactive with the HTLV-II ANTIGENS. Human T-Cell Leukemia Virus II Antibodies,Human T-Lymphotropic Virus II Antibodies,Leukemia-Lymphoma Virus II Antibodies, Human T-Cell,T-Cell Leukemia Virus II Antibodies, Human,HTLV II Antibodies,Human T Cell Leukemia Virus II Antibodies,Human T Lymphotropic Virus II Antibodies,Leukemia Lymphoma Virus II Antibodies, Human T Cell,T Cell Leukemia Virus II Antibodies, Human,Antibodies, HTLV II,Antibodies, HTLV-II,II Antibodies, HTLV
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015491 HTLV-II Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2. Human T-lymphotropic Virus 2 Infection,Human T-lymphotropic Virus 2 Infections,Infections, HTLV-II,HTLV-II Infection,Human T lymphotropic Virus 2 Infection,Human T lymphotropic Virus 2 Infections,Infection, HTLV-II,Infections, HTLV II

Related Publications

J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
October 1996, Transfusion,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
February 2003, The Thoracic and cardiovascular surgeon,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
January 1982, Transfusion,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
February 1987, Revue francaise de transfusion et immuno-hematologie,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
March 2001, American heart journal,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
March 1976, The Yale journal of biology and medicine,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
January 1992, Journal of acquired immune deficiency syndromes,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
March 1972, Thorax,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
October 1999, Transfusion,
J W Shih, and H H Lee, and M Falchek, and M Canavaggio, and B W Jett, and J P Allain, and H J Alter
May 1992, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!